Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey Scott Riley currently holds 25,000 shares of Synthetic Biologics, Inc. (SYN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Scott Riley has been a net buyer of SYN stock. They have purchased $129.4K and sold $0 worth of shares.
Jeffrey Scott Riley's most recent insider trade was on Jul 15, 2026, when they sold 25,000 shares at $0.00 per share.
Jeffrey Scott Riley serves as Executive at Synthetic Biologics, Inc. (SYN). They have executed 8 insider transactions totaling $129.4K over their tenure at the company.
Jeffrey Scott Riley holds the position of Executive at Synthetic Biologics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Jeffrey Scott Riley has shown a buying trading pattern, with $129.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jeffrey Scott Riley was on Mar 28, 2024, when they purchased $115.8K worth of GANX shares. This transaction involved 30,000 shares at $3.86 per share.
Jeffrey Scott Riley currently owns 25,000 shares of Synthetic Biologics, Inc. (SYN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey Scott Riley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey Scott Riley has 8 Form 4 filings on record as an insider at Synthetic Biologics, Inc..
Set alerts for Jeffrey Scott Riley and 40,000+ other insiders.